GPCM
APLT

Granite Point Capital Management’s Applied Therapeutics APLT Stock Holding History

Granite Point Capital Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-38,240
Closed -$1.25M – 142
2020
Q1 		$1.25M Buy
38,240
+26,339
+221% +$1.07M 0.71% 41
2019
Q4 		$325K Buy
+11,901
New +$204K 0.05% 77

Other funds holding APLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Granite Point Capital Management's APLT Position: Q2 2020 in Review

Granite Point Capital Management sold out of Applied Therapeutics (APLT) in Q2 2020, closing a stake of 38,240 shares — an estimated $1.25M sold.

Granite Point Capital Management first reported a position in APLT in Q4 2019 and held it in 2 quarters. The position peaked at $1.25M in Q1 2020. 73 funds tracked by Wall St. Rank hold APLT as of Q2 2020.

  • Granite Point Capital Management reported no remaining Applied Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Granite Point Capital Management sold 38,240 Applied Therapeutics shares in Q2 2020, an estimated $1.25M.
  • Granite Point Capital Management first reported a position in Applied Therapeutics in Q4 2019 and held it in 2 quarters.
  • Granite Point Capital Management's Applied Therapeutics position peaked at $1.25M in Q1 2020.
  • 73 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2020.

Based on Granite Point Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.